spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  spinal cord 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 11 Feb 2025
Neuvotion Receives FDA Clearance for NeuStim(TM) Providing Non-Invasive, High-Resolution Stimulation for the Hand After Stroke or Spinal Cord Injury
Devices Neurology FDA
 HSMN NewsFeed - 12 Nov 2024
Nevro's HFX iQ(TM) Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally
Devices Regulatory
 HSMN NewsFeed - 5 Aug 2024
Dignify Therapeutics welcomes leading spinal injury expert Alexander "Sasha" Rabchevsky PhD, to its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 May 2024
US FDA Awards Supplemental Orphan Drug Designation to Survaxm to Now Include Treatment of Malignant Glioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Jan 2024
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 25 Aug 2023
Medtronic receives CE Mark approval for Inceptiv(TM) spinal cord stimulator with closed-loop sensing to treat chronic pain
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 7 Aug 2023
NRx Pharmaceuticals Announces the Licensure of a US Patent to Support Use of NRX-101(TM) for Chronic Pain
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Apr 2023
Reach Neuro Receives FDA Breakthrough Device Designation for Device to Restore Arm and Hand Movement to Chronic Stroke Patients
Devices Neurology FDA
 HSMN NewsFeed - 26 Jan 2023
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Devices Neurology FDA
 HSMN NewsFeed - 19 Dec 2022
Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain
Devices FDA Product Launch
 HSMN NewsFeed - 13 Dec 2022
Neurolief Appoints Neuromodulation Industry Leader Scott Drees as CEO
Devices Neurology Personnel
 HSMN NewsFeed - 4 Oct 2022
Saluda Medical Appoints Laureen DeBuono to Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 1 Sep 2022
Nevro Announces Multiple Positive Coverage Updates for the Treatment of Painful Diabetic Neuropathy
Devices Reimbursement
 HSMN NewsFeed - 5 Jul 2022
Newly Released Clinical Data Demonstrates Substantial Improvement in Overall Health-Related Quality of Life in Patients with Painful Diabetic Neuropathy Treated with Nevro HFX Spinal Cord Stimulation Therapy
Devices Neurology
 HSMN NewsFeed - 29 Mar 2022
Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells(R) treatment for Traumatic Spinal Cord Injury
Regenerative Medicine Neurology
 HSMN NewsFeed - 11 Feb 2022
Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine
Devices Neurosurgery
 HSMN NewsFeed - 4 Jan 2022
Abbott's Proclaim(TM) XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in U.S.
Devices Neurology Radiology FDA
 HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 27 Aug 2021
European Commission Approves BioMarin's VOXZOGO(R) (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Jul 2021
FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
Devices FDA
 HSMN NewsFeed - 19 Jul 2021
Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 25 Jun 2021
BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Apr 2021
Nevro Appoints Jon R. Shear as Vice President, Corporate Development
Devices Personnel
 HSMN NewsFeed - 8 Mar 2021
Abbott Introduces NeuroSphere(TM) Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.
Devices Neurology Product Launch
 HSMN NewsFeed - 14 Jan 2021
Abbott to Launch the NeuroSphere(TM) myPath(TM) Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant
Devices Neurology Monitoring Product Launch
 HSMN NewsFeed - 4 Jan 2021
Flowonix Medical, Inc. and SWK Holdings Corporation Announce Closing of $33 Million Financing
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 15 Dec 2020
Medtronic's OsteoCool(TM) Procedure Shows Significant, Swift Pain Relief and Sustained Improvement for Cancer Patients
Devices Interventional Oncology
 HSMN NewsFeed - 13 Oct 2020
Chord Therapeutics launches with USD 16 million Series A financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 20 Aug 2020
BioMarin Submits New Drug Application to U.S. Food and Drug Administration for Vosoritide to Treat Children with Achondroplasia
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jun 2020
Quest Products, LLC Acquires Summit Pharmaceuticals / Alliance Labs, Including Enemeez(R) and DocuSol(R) Brands
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Jun 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX(R) (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 Jun 2020
Vesiflo Announces Medicare Coverage of the inFlow(TM) Device for Women
Devices Urology Reimbursement
 HSMN NewsFeed - 9 Jun 2020
Saluda Medical Appoints Jim Schuermann as President and Robert Gaffney as Chief Operating Officer
Devices Neurology Personnel
 HSMN NewsFeed - 4 Jun 2020
Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 15 Apr 2020
Synapse Biomedical Receives FDA Emergency Use Authorization for New System to Assist in Weaning Patients off of Ventilators During COVID-19 Pandemic
Devices FDA
 HSMN NewsFeed - 28 Feb 2020
Nevro and Stimwave Reach Worldwide Settlement in Patent Infringement Lawsuit: Stimwave Agrees to a Permanent Injunction
Devices Neurology Litigation
 HSMN NewsFeed - 28 Feb 2020
Nevro Files Lawsuit for Patent Infringement Against Nalu Medical in the U.S.
Devices Neurology Litigation
 HSMN NewsFeed - 22 Jan 2020
Soin Neuroscience Develops A New Spinal Cord Stimulator to Treat Chronic Pain
Devices Neurology
 HSMN NewsFeed - 20 Jan 2020
Nevro Names Donald A. Middlebrook to Lead Clinical, Regulatory and Quality
Devices Neurology Personnel
 HSMN NewsFeed - 18 Dec 2019
Nevro Appoints Karen N. Prange to the Company's Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 12 Dec 2019
Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 9 Dec 2019
HIZENTRA(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Nov 2019
Nevro Announces U.S. Launch of Senza(R) Omnia(TM) Spinal Cord Stimulation System to Treat Chronic Pain
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 26 Sep 2019
FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain
Devices Neurology FDA
 HSMN NewsFeed - 16 Sep 2019
Saluda Medical Announces European Commercial Launch of Evoke(R), the First and Only ECAP-Controlled, Closed-Loop SCS System for Chronic Pain Relief
Devices Regulatory Product Launch
 HSMN NewsFeed - 28 Aug 2019
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 25 Jul 2019
PathMaker Neurosystems Announces Publication of First Clinical Trial Results for its MyoRegulator(R) Device for Non-Invasive Treatment of Spasticity
Devices Neurology
 HSMN NewsFeed - 25 Jul 2019
Nevro Announces Court Order Granting Preliminary Injunction Against Stimwave Technologies, Inc.
Devices Litigation
 HSMN NewsFeed - 22 Jul 2019
Zynex Expands Executive Team, Appoints Joseph Papandrea Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 18 Jul 2019
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 28 Jun 2019
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
Devices Neurology Venture Capital
 HSMN NewsFeed - 25 Jun 2019
Nevro Announces Executive Appointments
Devices Personnel
 HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jun 2019
Saluda Medical Announces Clinical Study Results for Evoke(R) ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain
Devices Neurosurgery
 HSMN NewsFeed - 29 May 2019
ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device
Devices Regulatory
 HSMN NewsFeed - 9 May 2019
Boston Scientific Announces Agreement To Acquire Vertiflex, Inc.
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Mar 2019
RDD Pharma Appoints John Temperato as Chief Executive Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 28 Feb 2019
Zynex names new Vice President of Sales and Marketing
Devices Neurology Personnel
 HSMN NewsFeed - 19 Feb 2019
ReWalk Announces 510k FDA Submission for ReStore(TM) Exo-Suit for Stroke Rehabilitation
Devices FDA
 HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Biopharmaceuticals
 HSMN NewsFeed - 15 Feb 2019
Nevro Files Lawsuit for Patent Infringement Against Stimwave in the U.S.
Devices Neurology Litigation
 HSMN NewsFeed - 13 Feb 2019
ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices
Devices Reimbursement
 HSMN NewsFeed - 11 Feb 2019
FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Dec 2018
BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to AbbVie After Receiving Clearance
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 3 Dec 2018
Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with argenx for Cancer Immunotherapy Cusatuzumab
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 26 Nov 2018
Biohaven Announces FDA Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology Drug Delivery FDA
 HSMN NewsFeed - 15 Nov 2018
New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant
Devices Neurology FDA Regulatory Product Launch
 HSMN NewsFeed - 9 Nov 2018
ReWalk Announces Placement of 500th Exoskeleton System
Devices
 HSMN NewsFeed - 2 Nov 2018
BioArctic's Partner AbbVie Exercises its Option to License the Alpha-synuclein Antibody Portfolio for Parkinson's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 24 Oct 2018
FDA Approves New SynchroMed(TM) II myPTM(TM) Personal Therapy Manager That Enables Patients to Alleviate Unpredictable Pain
Devices Drug Delivery Neurology FDA
 HSMN NewsFeed - 23 Oct 2018
CavoGene LifeSciences Licenses Novel Gene Therapy for CNS Disorders
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 12 Oct 2018
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Jul 2018
Nevro Announces Patent Litigation Update
Devices Neurology Litigation
 HSMN NewsFeed - 25 Jul 2018
Nevro Announces Patent Litigation Update
Devices Neurology Litigation
 HSMN NewsFeed - 6 Jul 2018
BioArctic Announces Positive Topline Results of BAN2401 Phase 2b at 18 Months in Early Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2018
RDD Pharma Appoints Dr. Mark Sirgo as Board Chairman
Biopharmaceuticals Gatroenterology Personnel
 HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 15 May 2018
BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
Devices Neurology Venture Capital
 HSMN NewsFeed - 26 Apr 2018
Neuraltus Pharmaceuticals Reports Results from Phase 2 NP001 Study in Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Mar 2018
Bioness Receives FDA Clearance for myBioness(TM) iOS app for mobile control of the L300 Go(TM) System
Devices FDA
 HSMN NewsFeed - 16 Mar 2018
FDA Approves Hizentra(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Feb 2018
Amgen Receives Positive Opinion Expanding Use Of XGEVA(R) (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Feb 2018
Zynex introduces the NeuroMove(TM) Device to its expanding sales force
Devices Product Launch
 HSMN NewsFeed - 29 Jan 2018
Bioness Receives Health Canada Approval for StimRouter Neuromodulation System
Devices Neurology Regulatory
 HSMN NewsFeed - 12 Jan 2018
Boston Scientific Announces Positive Results from WHISPER Spinal Cord Stimulation Study
Devices Neurology
 HSMN NewsFeed - 11 Jan 2018
New Study Shows Superiority of Intrathecal Baclofen Therapy (ITB Therapy(SM)) Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity
Devices Drug Delivery Neurology
 HSMN NewsFeed - 11 Jan 2018
Boston Scientific Receives U.S. FDA Approval for Spectra WaveWriter(TM) Spinal Cord Stimulator System
Devices Neurology FDA
 HSMN NewsFeed - 9 Jan 2018
New Absorbable Adjunctive Hemostat From Ethicon Helps Surgeons Control Disruptive Bleeding More Efficiently
Devices Surgery Product Launch
 HSMN NewsFeed - 8 Jan 2018
Nevro Receives FDA Approval for Senza II(TM) Spinal Cord Stimulation System Delivering HF10(TM) Therapy
Devices FDA
 HSMN NewsFeed - 5 Jan 2018
FDA Approves XGEVA(R) (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Nov 2017
RDD Pharma Raises $9.5M in Series B Funding to Fuel Global Development
Biopharmaceuticals Gastroenterology Venture Capital
 HSMN NewsFeed - 8 Aug 2017
First FDA-Approved Treatment For ALS In 22 Years Now Available In U.S.
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 20 Jul 2017
New Data Show TomoTherapy(R) System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers
Devices Oncology
 HSMN NewsFeed - 13 Jul 2017
American Society for Radiation Oncology Updates Insurance Coverage Recommendations for Proton Therapy
Devices Oncology
 HSMN NewsFeed - 12 Jul 2017
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
Regenerative Medicine Neurology
 HSMN NewsFeed - 28 Jun 2017
FDA Grants Profounda Inc. Orphan Drug Designation for treatment of Granulomatous Amebic Encephalitis (GAE) with Miltefosine
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jun 2017
FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA(R) (denosumab) To Include Multiple Myeloma Patients
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Jun 2017
Zynex Hires Chief Financial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 6 Jun 2017
Ethicon Announces FDA Approval For SURGICEL(R) Powder Absorbable Hemostat
Devices Surgery FDA
 HSMN NewsFeed - 1 Jun 2017
SPINRAZA(R) (nusinersen) Approved in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 May 2017
Saluda Medical Secures AU$53 Million in Series D Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 11 May 2017
New MRI Data from Asterias' Ongoing SCiStar Clinical Study Indicates AST-OPC1 Cells Prevent Formation of Damaging Lesion Cavities in Patients Suffering Severe Spinal Cord Injury
Regenerative Medicine Neurosurgery
 HSMN NewsFeed - 28 Apr 2017
ReWalk Robotics Names Jodi Gricci Chief Commercial Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 26 Apr 2017
Asterias Announces Publication of Positive Phase 2 Data on AST-VAC1 for the Treatment of Acute Myeloid Leukemia (AML) in 'Cancer'
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 29 Mar 2017
FDA Approves Genentech’s OCREVUS(TM) (Ocrelizumab) for Relapsing and Primary Progressive Forms of Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 27 Mar 2017
Dr. Reddy’s and Integra LifeSciences Enter into an Agreement to Market and Distribute DuraGen Plus(R) and Suturable DuraGen(R) Dural Regeneration in India
Devices Regenerative Medicine Neurosurgery Distribution
 HSMN NewsFeed - 7 Feb 2017
Bioness Receives FDA Clearance for the L300 Go(TM) System
Devices Orthopaedic FDA
 HSMN NewsFeed - 26 Dec 2016
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Dec 2016
Positive Phase III Results of Genentech’s Investigational Medicine OCREVUS(TM) (Ocrelizumab) Published in New England Journal of Medicine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Dec 2016
Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA(TM) (Daclizumab Beta) for Multiple Sclerosis
Biopharmaceuticals Nerurology Regulatory
 HSMN NewsFeed - 8 Dec 2016
St. Jude Medical Receives CE Mark Approval for Full Body MR Conditional Labeling for the Proclaim Elite Spinal Cord Stimulation System
Devices Neurology Regulatory
 HSMN NewsFeed - 29 Nov 2016
Nevro Files Lawsuit for Patent Infringement Against Boston Scientific in the U.S.
Devices Neurology Litigation
 HSMN NewsFeed - 14 Nov 2016
St. Jude Medical Announces Full-Body MRI Compatibility and Second Major Upgrade for Proclaim Elite Spinal Cord Stimulation System
Devices Neurology Radiology FDA Product Launch
 HSMN NewsFeed - 17 Oct 2016
French Study Of NeuRx(R) Diaphragm Pacing System (DPS) In Off-Label ALS Patients Confirms: NeuRx DPS(R) Should Be Used With NIV In Later Stage Of Disease
Devices Neurology
 HSMN NewsFeed - 8 Sep 2016
Monteris Medical Receives IDE Approval From FDA To Evaluate NeuroBlate(R) In Patients Newly Diagnosed With Glioblastoma Multiforme
Devices Oncology Neurosurgery FDA
 HSMN NewsFeed - 6 Sep 2016
Publication of Two-Year SENZA-RCT Results in Neurosurgery Demonstrates Sustained Superiority of HF10(TM) Therapy over Traditional Spinal Cord Stimulation for Chronic Pain
Devices Neurology
 HSMN NewsFeed - 1 Aug 2016
Ipsen Biopharmaceuticals, Inc. Announces FDA Approval of Dysport(R) (Abobotulinumtoxin A) for the Treatment of Lower Limb Spasticity in Pediatric Patients Aged Two and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Jul 2016
Boston Scientific Announces Acquisition of Cosman Medical
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 28 Jun 2016
FDA Grants Priority Review for Genentech’s OCREVUS(TM) (ocrelizumab) Biologics License Application
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Jun 2016
Zynex Hires Vice President of Operations
Devices Personnel
 HSMN NewsFeed - 20 May 2016
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
Regenerative Medicine Neurology
 HSMN NewsFeed - 19 May 2016
Boston Scientific Receives U.S. FDA Approval for Precision Montage(TM) MRI Spinal Cord Stimulator System
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 28 Apr 2016
Abbott to Acquire St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 11 Apr 2016
St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy
Devices Neurology Product Launch
 HSMN NewsFeed - 4 Apr 2016
Ekso GT(TM) Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients
Devices Neurology FDA
 HSMN NewsFeed - 29 Feb 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 17 Feb 2016
FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine Ocrelizumab in Primary Progressive Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 3 Feb 2016
ProtoStar(TM) Announces the LifeWalker(TM) Upright, a New Medical Walker Designed to Enable Users to Stand Upright and Walk Safer and Longer for Improved Health
Devices Product Launch
 HSMN NewsFeed - 1 Feb 2016
Bioness Announces the Publication of StimRouter(TM) Neuromodulation System Clinical Trial
Devices Neurology
 HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Nov 2015
St. Jude Medical Announces European Launch of the World’s First and Only Upgradeable, Non-Rechargeable, Burst-Enabled MR-Conditional SCS System
Devices Neurology Product Launch
 HSMN NewsFeed - 19 Nov 2015
St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option
Devices Neurology FDA
 HSMN NewsFeed - 23 Oct 2015
InVivo Therapeutics Reports Significant Improvement of First Patient Implanted with Neuro-Spinal Scaffold(TM)
Devices Neurosurgery
 HSMN NewsFeed - 12 Oct 2015
NuVasive Receives First Ever FDA 510(k) Clearance of Cervical Corpectomy Cage
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 15 Sep 2015
Marathon Pharmaceuticals Names Dr. Jordan Dubow Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Aug 2015
St. Jude Medical Receives CE Mark for Industry's Only MR-Conditional Rechargeable Spinal Cord Stimulator Approved to Offer Burst Stimulation
Devices Neurology Regulatory
 HSMN NewsFeed - 11 Aug 2015
Axiobionics(R) Announces the Launch of its Newest Therapy Device: TripleFlex
Devices Neurology Product Launch
 HSMN NewsFeed - 20 Jul 2015
St. Jude Medical Announces FDA Approval for Industry's Only MR-Conditional 5-Column Paddle Lead for the Management of Chronic Pain
Devices Neurology FDA
 HSMN NewsFeed - 15 Jul 2015
OncoCyte Announces Appointment of Andy Arno to Board of Directors
Diagnostics Oncology Personnel
 HSMN NewsFeed - 14 Jul 2015
New TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
Devices Oncology
 HSMN NewsFeed - 16 Jun 2015
William Annett Named Chief Executive Officer of OncoCyte Corporation
Diagnostics Oncology Personnel
 HSMN NewsFeed - 18 May 2015
Vesiflo Introduces the inFlow Device and Its Companion Patient Monitoring System
Devices Urology Product Launch
 HSMN NewsFeed - 14 May 2015
InVivo Therapeutics Reports Update of First Two Spinal Cord Injury Patients Implanted with Neuro-Spinal Scaffold
Devices Neurosurgery
 HSMN NewsFeed - 14 May 2015
OncoCyte Corporation Completes Equity Financing Round
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 4 May 2015
St. Jude Medical Completes Acquisition of Spinal Modulation, Inc.
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 30 Apr 2015
St. Jude Medical Receives FDA Approval for the World’s Smallest Upgradeable MR-Conditional Spinal Cord Stimulation System
Devices Neurology FDA
 HSMN NewsFeed - 8 Apr 2015
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Apr 2015
InVivo Therapeutics Announces New Clinical Trial Site for Neuro-Spinal Scaffold
Devices Neurosurgery Neurology
 HSMN NewsFeed - 24 Mar 2015
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 9 Feb 2015
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
Devices Neurology Personnel
 HSMN NewsFeed - 29 Dec 2014
BioTime Appoints Adi Mohanty Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
Regenerative Medicine HIV/AIDS
 HSMN NewsFeed - 22 Jul 2014
Multi-Center Trial Shows Significant Pain Relief for Spine Cancer Patients Following Targeted Radiofrequency Ablation Treatment
Devices Oncology
 HSMN NewsFeed - 21 Jul 2014
Zynex Announces Brian Alleman as Chief Financial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 25 Jun 2014
Zynex Appoints Director of Business Development
Devices Personnel
 HSMN NewsFeed - 4 Jun 2014
Ultrasonic BoneScalpel(TM) Making Spine Surgery Safe and Efficient
Devices Surgery
 HSMN NewsFeed - 2 Jun 2014
Doctors at Community Cancer Center Treat Inoperable Lung Cancer Using TrueBeam System for Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 19 May 2014
Pamela Youde Nethersole Eastern Hospital First in Asia to Treat Cancer using TrueBeam 2.0 System for Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2014
World's First and Only Upgradeable Spinal Cord Stimulation System Receives FDA Approval
Devices Neurology FDA
 HSMN NewsFeed - 3 Apr 2014
Astellas Announces European Regulatory Submission For XTANDI(R) (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Apr 2014
Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 20 Mar 2014
St. Jude Medical Announces European Launch of Prodigy Spinal Cord Stimulation System with Burst Technology
Devices Neurology Product Launch
 HSMN NewsFeed - 19 Mar 2014
IsoRay Announces World's First Pediatric Cesium-131 Seeded Mesh Treatment for Metastatic Wilms Tumor
Devices Oncology
 HSMN NewsFeed - 24 Feb 2014
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 29 Jan 2014
XenoPort Appoints Richard Kim, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Jan 2014
Neuralstem Appoints Catherine Angell Sohn To Board Of Directors
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 7 Jan 2014
Zynex Appoints Vice President of Sales for NeuroDiagnostics Division
Devices Neurology Personnel
 HSMN NewsFeed - 6 Jan 2014
Medtronic Announces Acquisition of TYRX, INC., Developer of Solutions for Surgical Site Infections
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 9 Dec 2013
InVivo Therapeutics Announces Promotions in Technical Operations
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 6 Dec 2013
Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra(TM) Spinal Cord Stimulator System
Devices Neurology
 HSMN NewsFeed - 3 Dec 2013
St. Jude Medical Launches US Study of New Prodigy Neurostimulator to Evaluate Burst Stimulation Technology for Chronic Pain
Devices Neurology
 HSMN NewsFeed - 19 Nov 2013
EBS Technologies Appoints Karl Schweitzer, JD, MBA, Medtronic’s Former Vice President and General Manager of Neuromodulation, as a Director
Devices Ophthalmology Neurology Personnel
 HSMN NewsFeed - 23 Oct 2013
Baxter Launches HEMOPATCH, an Innovative Sealing Hemostat, in European Union
Devices Surgery Product Launch
 HSMN NewsFeed - 17 Oct 2013
Pfizer Receives European Approval For Label Update Regarding The Use Of Prevenar 13 In Certain High-Risk Populations
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Oct 2013
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Oct 2013
Integra LifeSciences Receives FDA Clearance for Integra(R) Laminoplasty System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 9 Oct 2013
DFINE Announces First Commercial Cases with STAR(TM) Tumor Ablation System in Europe
Devices Orthopaedic Neurosurgery Oncology Product Launch
 HSMN NewsFeed - 7 Oct 2013
Acorda Therapeutics Appoints Michael Rogers Chief Financial Officer; David Lawrence Named Chief of Business Operations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Sep 2013
Bioness Appoints Todd Cushman as President & CEO
Devices Neurology Personnel
 HSMN NewsFeed - 20 Sep 2013
New York Proton Consortium Expands Access to Proton Therapy Through Agreement with ProCure Proton Therapy Center in New Jersey
Devices Oncology
 HSMN NewsFeed - 17 Sep 2013
InVivo Therapeutics Appoints Gregory D. Perry as Interim CFO
Devices Neurosurgery Personnel
 HSMN NewsFeed - 5 Sep 2013
Neuralstem To Raise $4 Million In Registered Direct Offering
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 6 Aug 2013
Medtronic Introduces the First and Only Neurostimulation Systems for Chronic Pain Designed for Full-Body MRI Safety*
Devices Neurology Product Launch
 HSMN NewsFeed - 23 Jul 2013
XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatment of Restless Legs Syndrome/Willis-Ekbom Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Jul 2013
Boston Scientific Launches Trial To Evaluate Neurostimulation For Treatment Of Chronic Migraine
Devices Neurology
 HSMN NewsFeed - 16 Jul 2013
Alexion’s Soliris(R) (eculizumab) Receives Positive Opinion from the Committee for Orphan Medicinal Products for Treatment of Neuromyelitis Optica (NMO)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 9 Jul 2013
VIVUS Announces Avanafil Partnership With Menarini
Biopharmaceuticals Licensing
 HSMN NewsFeed - 26 Jun 2013
VIVUS Announces SPEDRA (avanafil) Approval in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jun 2013
XTANDI(TM) (Enzalutamide) Authorized in the European Union for Advanced Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Jun 2013
Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
Biopharmaceuticals Distribution
 HSMN NewsFeed - 24 May 2013
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 30 Apr 2013
Kevin M. Smith Appointed to Zynex Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 25 Apr 2013
The StabiLink(TM) MIS Spinal Fixation System Offers New Minimally Invasive Option for Spine Surgeons
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 4 Apr 2013
InVivo Therapeutics Receives Humanitarian Use Device Designation for Spinal Cord Injury Treatment
Devices Neurosurgery
 HSMN NewsFeed - 26 Mar 2013
Misonix BoneScalpel(TM) Subject of New Clinical Paper Focused on Spine Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 28 Feb 2013
InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study
Devices Neurology FDA
 HSMN NewsFeed - 21 Feb 2013
Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Jan 2013
Acorda Therapeutics Announces Department of Defense Contract to Support Study of AC105 in Acute Spinal Cord Injury
Biopharmaceuticals Neurology Neurosurgery
 HSMN NewsFeed - 22 Jan 2013
Clinical Trials Advancing Proton Therapy Research Open at the CDH Proton Center, A ProCure Center
Devices Oncology
 HSMN NewsFeed - 21 Jan 2013
Mallinckrodt Announces Approval of New Gablofen(R) Prefilled Syringe
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 21 Jan 2013
Parker Names New Exoskeleton Device Indego(TM)
Devices Neurology
 HSMN NewsFeed - 14 Jan 2013
Neuralstem Receives FDA Approval To Commence Spinal Cord Injury Trial
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 21 Dec 2012
Acorda Therapeutics Announces Completion of Neuronex, Inc. Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2012
Biogen Executive Kenneth DiPietro Joins InVivo Therapeutics Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 18 Dec 2012
GRUPO COI First In South America to Order a TrueBeam(TM) System for Treating Cancer with Advanced Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 14 Dec 2012
InVivo Therapeutics Requests Humanitarian Use Device Designation with FDA
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 7 Dec 2012
Boston Scientific Receives European Regulatory Approval For New Precision Spectra(TM) Spinal Cord Stimulator System
Devices Neurology Regulatory
 HSMN NewsFeed - 9 Oct 2012
Acorda Therapeutics Names Jane Wasman President, International
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2012
InVivo Therapeutics Appoints Brian Hess as Interim Chief Science Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Sep 2012
InVivo Therapeutics Announces Business Updates
Devices Neurology
 HSMN NewsFeed - 30 Aug 2012
Zynex Receives FDA 510(k) Clearance for InWave Medical Device
Devices Urology FDA
 HSMN NewsFeed - 6 Aug 2012
Life of Cancer Patient Suffering From Bone Marrow Failure Saved Following Treatment With Pluristem's PLX Cells
Regenerative Medicine Oncology
 HSMN NewsFeed - 18 Jul 2012
Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 10 Jul 2012
First Patient Treated in Landmark U.S. Randomized Pivotal Trial of Nevro’s Chronic Pain Treatment
Devices
 HSMN NewsFeed - 21 Jun 2012
FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jun 2012
Neuralstem Updates ALS Stem Cell Trial Progress; Emory University Institutional Review Board Approves Amendment
Biopharmaceuticals Regenerative Medicine Neurology
 HSMN NewsFeed - 30 May 2012
Former Stryker Executive Robert Housler Jr. Joins InVivo Therapeutics as Vice President of Business Development
Devices Personnel
 HSMN NewsFeed - 17 May 2012
Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer
Devices Oncology
 HSMN NewsFeed - 15 May 2012
Spinal Kinetics Wins Another Round in Synthes' Patent Litigation
Devices Neurosurgery Orthopaedic Litigation
 HSMN NewsFeed - 14 May 2012
Bioness Announces FDA Clearance of Smaller Leg Cuff for Use with Its L300 Foot Drop System
Devices Neurology FDA
 HSMN NewsFeed - 11 May 2012
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 9 May 2012
Varian Medical Systems Redesigns its ProBeam(TM) Proton Therapy User Interface
Devices Oncology
 HSMN NewsFeed - 13 Apr 2012
BOTOX(R) Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 11 Apr 2012
Varian Medical Systems to Showcase TrueBeam(TM) STx with RapidArc(R) Radiosurgery - Technology for Fast, Precise Stereotactic Radiosurgery - at AANS Meeting
Devices Neurosurgery Oncology
 HSMN NewsFeed - 4 Apr 2012
Anulex Technologies, Inc. Announces FDA Clearance for Expanded Indications of fiXate(TM) Tissue Band
Devices Neurology FDA
 HSMN NewsFeed - 23 Mar 2012
Ascendx Spine(TM) Appoints Eric W. Gilbert as Vice President of Sales & Marketing for its U.S. Operations
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 12 Mar 2012
Zynex Acquires NeuroDyne Medical, Corp.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 22 Feb 2012
Stryker’s 2010 Innovator of the Year Brian Hess Joins InVivo Therapeutics as Director of Product Development
Devices Personnel
 HSMN NewsFeed - 21 Feb 2012
Arno Therapeutics Receives Two Orphan-Drug Designations for AR-42 in Treatment of Central-Nervous-System Tumors
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 Dec 2011
Boston Scientific Receives FDA Approval for New Infinion(TM) 16 Percutaneous Lead for Precision Plus(TM) Spinal Cord Stimulator System
Devices Neurology FDA
 HSMN NewsFeed - 8 Dec 2011
Spinal Modulation System Receives CE Mark for the Management of Chronic Intractable Pain
Devices Neurology Regulatory
 HSMN NewsFeed - 15 Nov 2011
Mid Atlantic Spine and Pain Physicians Perform Region’s First Procedure Using New Device from St. Jude Medical
Devices Orthopaedic Neurosurgery Neurology
 HSMN NewsFeed - 3 Nov 2011
Medtronic Announces Global Launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 28 Oct 2011
Spinal USA Gets FDA Approval for Two New Spinal Treatment Products
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 27 Oct 2011
Pfizer Receives European Approval to Extend Use of Prevenar 13 to Adults 50 Years and Older for the Prevention of Invasive Pneumococcal Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2011
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Regenerative Medicine Neurology
 HSMN NewsFeed - 5 Oct 2011
Major Diagnostic Breakthrough in Multiple Sclerosis Achieved with Advanced FONAR UPRIGHT(R) MRI
Devices Radiology Neurology
 HSMN NewsFeed - 26 Sep 2011
Zynex Receives FDA 510(k) Clearance for the NexWave Medical Device
Devices Neurology FDA
 HSMN NewsFeed - 20 Sep 2011
Anulex Technologies, Inc. Announces FDA Clearance of the fiXate(TM) Tissue Band
Devices Neurology FDA
 HSMN NewsFeed - 15 Sep 2011
Medtronic Announces 510(k) Clearance for the TSRH(R) Spinal System Pedicle Screw for the Treatment of Adolescent Idiopathic Scoliosis
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 15 Sep 2011
Study Shows Use of PediGuard(R) Reduced the Incidence of Clinically Relevant Misplaced Pedicle Screws in Spine Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 15 Sep 2011
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2011
InVivo Therapeutics Promotes Lauren Mitarotondo to Vice President, Operations as InVivo Prepares for Human Studies
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Aug 2011
Zynex Appoints Vice President of Reimbursement and Billing
Devices Personnel
 HSMN NewsFeed - 30 Aug 2011
Progenics and Salix Announce FDA Acceptance of sNDA Filing for RELISTOR(R) in Patients with Non-Cancer Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Jul 2011
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Jul 2011
St. Jude Medical Announces FDA Clearance for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Devices FDA
 HSMN NewsFeed - 21 Jun 2011
Pfizer’s Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury
Biopharmaceuticals
 HSMN NewsFeed - 14 Jun 2011
Neuralstem Updates ALS Clinical Trial Progress
Regenerative Medicine Neurology
 HSMN NewsFeed - 23 May 2011
St. Jude Medical Announces Australian Market Launch for First-of-Its-Kind Neurostimulation Lead Delivery System for Chronic Pain
Devices
 HSMN NewsFeed - 20 May 2011
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 May 2011
Varian Medical Systems Spotlights Fully Integrated Intensity Modulated Proton Therapy at PTCOG 2011 Meeting
Devices Oncology
 HSMN NewsFeed - 19 Apr 2011
Geron Announces the Appointment of Melanie Nallicheri as Senior Vice President of Corporate Development for Cell Therapies
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2011
Novartis Therapy Gilenya Reduced the Risk of MS Disability Progression Regardless of Treatment History or Disease Severity, New Analysis Shows
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Mar 2011
Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 31 Mar 2011
RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 24 Mar 2011
Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
Devices Neurology Pain Management FDA
 HSMN NewsFeed - 17 Mar 2011
Nevro Appoints Michael DeMane President and Chief Executive Officer
Devices Neurology Personnel
 HSMN NewsFeed - 10 Mar 2011
Medtronic Introduces the ATLANTIS VISION(R) ELITE Anterior Cervical Plate System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 1 Mar 2011
Arrival of 220-Ton Cyclotron Marks a Major Milestone in Construction of Metro New York’s First Proton Therapy Center
Devices Oncology
 HSMN NewsFeed - 17 Feb 2011
InVivo Therapeutics Appoints Phil Pereira Director of Manufacturing
Devices Personnel
 HSMN NewsFeed - 10 Feb 2011
Neuralstem Updates ALS Clinical Trial Progress
Regenerative Medicine Neurology
 HSMN NewsFeed - 9 Feb 2011
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Feb 2011
Geron Appoints David Greenwood President, Interim CEO and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2011
BrainStorm Appoints Dr. Adrian Harel as Chief Operating Officer and Acting Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 19 Jan 2011
First Patients Complete Proton Therapy Treatment at CDH Proton Center, A ProCure Center
Devices Oncology
 HSMN NewsFeed - 29 Dec 2010
Zynex Strengthens Management Team; Adds Regulatory Compliance Expert
Devices Personnel
 HSMN NewsFeed - 10 Dec 2010
Spinal Cord Injury Patient Treated With Non-Matched Adult Stem Cells
Regenerative Medicine Neurology
 HSMN NewsFeed - 9 Dec 2010
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Dec 2010
StemCells, Inc. Receives Authorization to Conduct World's First Neural Stem Cell Trial in Spinal Cord Injury
Regenerative Medicine Neurology
 HSMN NewsFeed - 3 Dec 2010
St. Jude Medical Neurostimulation Study Demonstrates Sustained Improvement in Chronic Low Back Pain Symptoms and Quality of Life
Devices Neurology
 HSMN NewsFeed - 2 Dec 2010
St. Jude Medical Announces New Approvals of Five-Column Neurostimulation Lead to Manage Chronic Pain at 14th Annual North American Neuromodulation Society Meeting
Devices Neurology Regulatory
 HSMN NewsFeed - 30 Nov 2010
X-spine Announces New FDA Product Clearance
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 30 Nov 2010
Zynex, Inc. Appoints President of Subsidiary, Zynex NeuroDiagnostic
Devices Neurology Personnel
 HSMN NewsFeed - 23 Nov 2010
FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen(R) (Baclofen Injection) for the Treatment of Severe Spasticity
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Nov 2010
Robert Cozart Promoted to VP of Technical Operations at Zynex
Devices Pain Management Personnel
 HSMN NewsFeed - 9 Nov 2010
Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep Brain Stimulation for Parkinson's Disease
Devices Neurology
 HSMN NewsFeed - 25 Oct 2010
Major Medical Center in India is Country's First to Offer Fast Arc-based Radiation Therapy Technique for Patients With Cancer
Devices Oncology
 HSMN NewsFeed - 11 Oct 2010
Chongqing Cancer Hospital Becomes First Hospital in Southwest China to Offer Cancer Patients Fast, Precise Treatment Using RapidArc(R) Radiotherapy from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 5 Oct 2010
Urovalve Announces Early Successful Results in 13 Patients Treated in Clinical Trial of Its Surinate(R) Bladder Management System
Devices Urology
 HSMN NewsFeed - 30 Sep 2010
St. Jude Medical Announces Approval of the First Rechargeable Neurostimulator to Manage Chronic Pain in Japan
Devices Neurology Regulatory
 HSMN NewsFeed - 27 Sep 2010
Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections
Devices
 HSMN NewsFeed - 22 Sep 2010
Novartis gains FDA approval for Gilenya, a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Aug 2010
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
Regenerative Medicine
 HSMN NewsFeed - 29 Jul 2010
Boston Scientific Announces FDA Approval of New Leads for the Precision Plus Spinal Cord Stimulator System
Devices Neurology FDA
 HSMN NewsFeed - 29 Jul 2010
Medtronic Launches Novel Clinical Trial Evaluating Spinal Cord Stimulation Therapy for Heart Failure
Devices Cardiology Neurosurgery
 HSMN NewsFeed - 9 Jul 2010
Integra LifeSciences Introduces DuraGen Plus(R) Dural Regeneration Matrix - Spinal Matrix, for Repair of the Dura
Devices Neurosurgery
 HSMN NewsFeed - 7 Jul 2010
Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2010
Boston Scientific Announces FDA Approval and Launch of Lead Splitters for the Precision Plus Spinal Cord Stimulator System
Devices FDA
 HSMN NewsFeed - 10 Jun 2010
Quark Pharmaceuticals Closes $10 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 May 2010
St. Jude Medical Announces European Approval for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Devices Neurosurgery
 HSMN NewsFeed - 25 May 2010
SpineGuard Elects Founder of Danek Medical, Alan Olsen, as its Chairman
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 24 May 2010
Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 May 2010
Medtronic Announces Clinical Trial for Breakthrough Technology in Neurostimulation Therapy for Intractable Chronic Pain
Devices Neurology
 HSMN NewsFeed - 3 May 2010
Boston Scientific Begins Groundbreaking Clinical Trial Comparing Spinal Cord Stimulation to Spine Reoperation In Patients With Failed Back Surgery Syndrome
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 5 Apr 2010
Imaging and Conformality Highlighted in Study of TomoTherapy(R) Technology for Craniospinal Irradiation
Devices Oncology
 HSMN NewsFeed - 23 Mar 2010
Study Reveals TomoTherapy(R) Technology Plays Key Role in Enabling Concurrent Chemo-Radiation Treatments for Lung Cancer
Devices Oncology
 HSMN NewsFeed - 23 Mar 2010
First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity
Devices Neurology
 HSMN NewsFeed - 11 Mar 2010
Leading Varian-Equipped Proton Therapy Center Treats 100th Patient
Devices Oncology
 HSMN NewsFeed - 8 Mar 2010
Bioness Appoints New President and CEO
Devices Neurology Personnel
 HSMN NewsFeed - 3 Mar 2010
Geron Highlights Product Launch from Collaboration with Corning - the Synthemax Surface for Scalable Growth of Human Embryonic Stem Cells
Regenerative Medicine
 HSMN NewsFeed - 24 Feb 2010
Pfizer Receives FDA Approval for Prevnar 13 for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Feb 2010
MicroTransponder Raises $10 Million to Begin Clinical Trials of Wireless Neurostimulation for Chronic Pain and Obtain FDA Clearance
Devices Venture Capital Personnel
 HSMN NewsFeed - 22 Feb 2010
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2010
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of Delayed Graft Function in Kidney Transplant Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Feb 2010
Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Feb 2010
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 3 Feb 2010
Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Jan 2010
EpiCept Receives Orphan Drug Designation for EpiCept NP-1 in U.S.
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jan 2010
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2010
Acorda Therapeutics Announces FDA Approval of AMPYRA (dalfampridine) to Improve Walking in People with Multiple Sclerosis - Demonstrated by Increases in Walking Speed
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Jan 2010
Neuralstem Announces First Patient Treated in ALS Stem Cell Trial
Regenerative Medicine Neurology
 HSMN NewsFeed - 19 Jan 2010
Cancer Patients Gain Greater Access to Intensity Modulated Proton Therapy Treatments at Leading German Clinic
Devices Oncology
 HSMN NewsFeed - 18 Jan 2010
St. Jude Medical Announces Approval and Launch of Neurostimulation System in Japan
Devices Neurology Regulatory
 HSMN NewsFeed - 13 Jan 2010
FDA Gives TCA Cellular Therapy Green Light to Proceed with First ALS Adult Stem Cell Trial Using Patient's Own Stem Cells
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 13 Jan 2010
Stem Cell Assurance Names Dr. Kurt J. Wagner Chairman of the Board
Regenerative Medicine Personnel
 HSMN NewsFeed - 11 Jan 2010
VIVUS Announces Additional Results of Phase 3 avanafil Study in Erectile Dysfunction Showing Efficacy in 15 Minutes
Biopharmaceuticals
 HSMN NewsFeed - 30 Dec 2009
Pfizer Provides U.S. Regulatory Update On Prevnar 13 Vaccine
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Dec 2009
California Stem Cell, Inc Closes Series B Financing Round
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 18 Dec 2009
Medtronic Introduces the SOVEREIGN Spinal System for Lumbar Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 10 Dec 2009
Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2009
New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's RAPAFLO(R) (silodosin) for Benign Prostatic Hyperplasia (BPH) Symptom Relief
Biopharmaceuticals Urology
 HSMN NewsFeed - 8 Dec 2009
Stem Cell Based Treatment for Spinal Muscular Atrophy Receives Orphan Drug Designation
Regenerative Medicine FDA
 HSMN NewsFeed - 4 Dec 2009
St. Jude Medical Receives FDA Approval for Industry-First Five-Column Neurostimulation Lead to Manage Chronic Pain
Devices Neurology FDA
 HSMN NewsFeed - 3 Dec 2009
New Neurostimulation Patient Programming Software Enables More Thorough and Efficient Capture of Complex Pain Patterns
Devices FDA
 HSMN NewsFeed - 30 Nov 2009
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Nov 2009
SpineGuard elects founder of Danek Medical, Alan Olsen, as a director
Devices Radiology Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 18 Nov 2009
StemCells, Inc. Provides Update on NCL Program Meeting with FDA
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 18 Nov 2009
62-Year-Old Man Becomes First Patient in China Implanted with Rechargeable Neurostimulator for Chronic Pain
Devices
 HSMN NewsFeed - 11 Nov 2009
Covidien Introduces First FDA-Approved Spine Sealant
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 22 Sep 2009
Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Sep 2009
Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 21 Sep 2009
Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
Biopharmaceuticals
 HSMN NewsFeed - 10 Sep 2009
NeuroMetrix Names Thomas T. Higgins Chief Financial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 27 Aug 2009
Geron Comments on FDA Hold on Spinal Cord Injury Trial
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Aug 2009
XenoPort Appoints Dennis Fenton to Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2009
Patients Begin Enrolling into Investigator-Sponsored Phase 2 Trial of Antigenics' Oncophage(R) Cancer Vaccine in Newly Diagnosed Glioma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Aug 2009
New Delivery System for RELISTOR in Pre-Filled Syringes Submitted for U.S. and European Marketing Approval
Biopharmaceuticals
 HSMN NewsFeed - 1 Jul 2009
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 24 Jun 2009
Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
Devices Monitoring Cardiology Neurology
 HSMN NewsFeed - 4 Jun 2009
ImmunoCellular Therapeutics Reports Additional Data from Promising Brain Cancer Clinical Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 May 2009
Presentations at Leading Neurosurgery Meeting Highlight Benefits of CyberKnife Radiosurgery for the Treatment of CNS Indications
Devices Neurosurgery Oncology
 HSMN NewsFeed - 4 May 2009
Medtronic Introduces The PEEK PREVAIL Device for Neck Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 29 Apr 2009
Lyrica Significantly Reduced Pain and Improved Other Symptoms of Post-Traumatic Peripheral Nerve Pain, New Data Show
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Apr 2009
XenoPort Announces Election of Co-Promotion Option for Solzira
Biopharmaceuticals
 HSMN NewsFeed - 9 Apr 2009
Encouraging Results Published on Use of TomoTherapy in Lung Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 1 Apr 2009
Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2009
Cardium's InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapy's Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
Devices Neurosurgery
 HSMN NewsFeed - 26 Mar 2009
Neuraltus Pharmaceuticals Raises $17 Million Series A Funding
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 11 Mar 2009
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
Devices Neurology Cardiology Regulatory
 HSMN NewsFeed - 5 Mar 2009
NeuroMetrix to Reorganize US Sales Operations
Devices Personnel
 HSMN NewsFeed - 24 Feb 2009
St. Jude Medical Receives Australian TGA Regulatory and Reimbursement Approval for the World's Smallest and Longest-Lasting Rechargeable Neurostimulator to Treat Chronic Pain
Devices Regulatory
 HSMN NewsFeed - 20 Feb 2009
Neuralstem's ALS Trial on Clinical Hold
Regenerative Medicine Neurology
 HSMN NewsFeed - 30 Jan 2009
Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 26 Jan 2009
Targin(R) (Oral Oxycodone/Naloxone Prolonged-Release Tablet) now Launching Across Europe to Control Severe Chronic Pain With Significantly Reduced Risk of Opioid-Induced Constipation
Biopharmaceuticals
 HSMN NewsFeed - 23 Jan 2009
Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
Regenerative Medicine Neurosurgery FDA
 HSMN NewsFeed - 12 Jan 2009
InSet Technologies Completes $25 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 9 Jan 2009
GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Jan 2009
Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
Devices Neurosurgery Regenerative Medicine
 HSMN NewsFeed - 18 Dec 2008
StemCells, Inc. Receives FDA Approval To Initiate Clinical Trial Of HuCNS-SC® Cells In A Myelin Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 28 Nov 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2008
Newly Published Data from Long-Term Study Show Neurostimulation Provides Sustained Leg Pain Relief, Improved Quality of Life and Functional Capacity
Devices Neurosurgery
 HSMN NewsFeed - 29 Oct 2008
Boston Scientific Welcomes Passage of Federal Pain Care Legislation to Benefit Military Members and Veterans
Devices
 HSMN NewsFeed - 27 Oct 2008
UK's NICE Recommends Spinal Cord Stimulation for Patients with Chronic Neuropathic Pain
Devices
 HSMN NewsFeed - 14 Oct 2008
Medtronic Announces Launch of X-STOP(R) PEEK IPD(R) System for U.S. Patients Suffering from Symptoms of Lumbar Spinal Stenosis
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 14 Oct 2008
Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
Devices Drug Delivery Regenerative Medicine Neurology
 HSMN NewsFeed - 1 Oct 2008
Alnylam Appoints Industry Leader John Schmidt as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2008
OHSU Announces First Clinical Use in the Pacific Northwest of Novalis Tx(TM) Technology for Non-Invasive, Image-Guided Stereotactic Body Radiation Therapy (SBRT) and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 22 Sep 2008
OmniGuide Introduces The BeamPath Neuro(TM): A CO2 Laser Fiber for Brain And Spine Surgery
Devices Neurosurgery
 HSMN NewsFeed - 20 Sep 2008
Acorda Therapeutics Presents Additional Data from Second Positive Phase 3 Study of Fampridine-SR at World Congress on Treatment and Research in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Sep 2008
Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Sep 2008
The European Commission Grants Orphan Drug Designation to Alseres Pharmaceuticals' Spinal Cord Injury Treatment, Cethrin(R)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 17 Sep 2008
Former U.S. Army Parachutist Becomes First Person Implanted with the World's Smallest Neurostimulator to Treat Chronic Pain
Devices
 HSMN NewsFeed - 16 Sep 2008
GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 16 Sep 2008
Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
Devices Oncology
 HSMN NewsFeed - 2 Sep 2008
World Renowned ALS Expert From Harvard Medical School and Mass. General Hospital, Dr. Robert H. Brown Jr., Joins BrainStorm Cell Therapeutics Scientific Advisory Board
Regenerative Medicine Personnel
 HSMN NewsFeed - 25 Aug 2008
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 22 Aug 2008
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Aug 2008
Pain Therapeutics and King Pharmaceuticals Announce Final Data of REMOXY Phase III Study at World Pain Congress in Scotland
Biopharmaceuticals
 HSMN NewsFeed - 13 Aug 2008
St. Jude Medical Receives U.S. and European Approvals of EonC, the First Extended-Life Primary Cell Neurostimulator for the Treatment of Chronic Pain
Devices Neurology FDA Regulatory
 HSMN NewsFeed - 21 Jul 2008
Insmed Provides Update on IPLEX(TM) Programs
Biopharmaceuticals
 HSMN NewsFeed - 16 Jul 2008
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Jul 2008
XenoPort Appoints David A. Stamler, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2008
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 30 Jun 2008
Odanacatib, an Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jun 2008
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Jun 2008
Medtronic Announces First Clinical Data on Occipital Nerve Stimulation for Chronic Migraine to Be Presented at American Headache Society Meeting
Devices Neurology
 HSMN NewsFeed - 16 Jun 2008
FDA Approves Cymbalta(R) for the Management of Fibromyalgia
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jun 2008
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2008
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2008
Merck Serono's Rebif(R) Celebrates 10th Anniversary
BIopharmaceuticals Neurology
 HSMN NewsFeed - 2 Jun 2008
Acorda Therapeutics Announces Positive Data from Second Phase 3 Study of Fampridine-SR on Walking Ability in People with Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 May 2008
Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 May 2008
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Biopharmaceuticals
 HSMN NewsFeed - 27 May 2008
Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 May 2008
Cyberkinetics Announces Sale of Research Products Business
Devices
 HSMN NewsFeed - 12 May 2008
Neuralstem Responds to New StemCells, Inc. Lawsuit
Regenerative Medicine Litigation
 HSMN NewsFeed - 9 May 2008
St. Jude Medical to Launch New Brand Identity
Devices Cardiology
 HSMN NewsFeed - 7 May 2008
Neuralstem Sues StemCells, Inc. Over New Patent
Regenerative Medicine Neurology Litigation
 HSMN NewsFeed - 6 May 2008
Neuralstem Goes to Court for Summary Judgment Against StemCells, Inc.
Regenerative Medicine Neurology Litigation
 HSMN NewsFeed - 28 Apr 2008
DynaMed Systems Obtains FDA Approval to Study Its Traxon(R) Spinal Cord Repair Stimulation System in Acute Spinal Cord Injured (SCI) Patients
Devices Neurosurgery FDA
 HSMN NewsFeed - 24 Apr 2008
AANS/CNS and BrainLAB Announce Winner of 2008 International Research Fellowship
Neurosurgery
 HSMN NewsFeed - 24 Apr 2008
Integra Foundation Awards Grants to American Association of Neurological Surgeons
Neurosurgery
 HSMN NewsFeed - 22 Apr 2008
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
Biopharmaceuticals
 HSMN NewsFeed - 17 Apr 2008
Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
Biopharmaceuticals Diagnostics Neurology
 HSMN NewsFeed - 15 Apr 2008
Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
Regenerative Medicine Litigation
 HSMN NewsFeed - 14 Apr 2008
St. Jude Medical Receives FDA and CE Mark Approvals for the World's Smallest, Longest-Lasting Rechargeable Neurostimulator to Treat Chronic Pain
Devices FDA
 HSMN NewsFeed - 10 Apr 2008
COPAXONE(R) Significantly Reduced Annual Relapse Rates and Stabilized Disease Progression in Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Apr 2008
Quark Pharmaceuticals, Inc. Closes $27 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Apr 2008
Acorda Therapeutics Names John Librie Senior Vice President, Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2008
Wyeth and Progenics Announce RELISTOR Receives Canadian Marketing Approval
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Feb 2008
California Stem Cell, Inc. Concludes Series A Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 27 Feb 2008
SpineVision(R) Appoints Spine Industry Veteran James Coyle as Vice President of U.S. Sales
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 20 Feb 2008
Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
Regenerative Medicine Licensing
 HSMN NewsFeed - 19 Feb 2008
NeuroMetrix and Cyberkinetics Form Joint Venture to Develop Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology
 HSMN NewsFeed - 19 Feb 2008
Cyberkinetics and Neurometrix Form Joint Venture to Develop Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology
 HSMN NewsFeed - 15 Feb 2008
Q Therapeutics Announces Series B Investment
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Feb 2008
St. Jude Medical Receives FDA and CE Mark Approvals of Extended 10-Year Battery Life Claim for Rechargeable Neurostimulator
Devices Neurology FDA Regulatory
 HSMN NewsFeed - 11 Feb 2008
Cook Medical Enrolls First U.S. Patient in STABLE Aortic Dissection Trial
Devices Interventional
 HSMN NewsFeed - 7 Feb 2008
EpiCept Announces Encouraging Results of Phase II Trial for NP-1 Cream in Diabetic Peripheral Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 6 Feb 2008
Medtronic Receives U.S. FDA Approval for New Neurostimulator with Innovative Patient Programmer
Devices Neurology Pain Management FDA
 HSMN NewsFeed - 4 Feb 2008
Misonix Announces Distribution Agreement for New BoneScalpel(TM) Medical Device
Devices Distribution
 HSMN NewsFeed - 4 Feb 2008
Acorda Therapeutics Announces Acquisition of Aminopyridine and Pre-Clinical Assets from Neurorecovery, Inc.
Biopharmaceuticals Acquisitions Neurology
 HSMN NewsFeed - 28 Jan 2008
FDA Grants Medtronic Approval to Begin Clinical Trial of First Pacemaker System Designed for Safe Use In MRI Machines
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 25 Jan 2008
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jan 2008
Cook Medical Begins Patient Enrollment in STABLE Aortic Dissection Trial
Devices
 HSMN NewsFeed - 7 Jan 2008
Safer Spine Surgery: SpineVision(R) Reports Preliminary Data from Postmarketing Study of its PediGuard(TM) Device
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 4 Jan 2008
Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
Devices Mergers & Acquisitions
 HSMN NewsFeed - 3 Jan 2008
Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
Regenerative Medicine Urology
 HSMN NewsFeed - 2 Jan 2008
Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology
Devices Oncology FDA
 HSMN NewsFeed - 20 Dec 2007
Marketing of Viadur(R) (leuprolide acetate implant) to Phase Out by April 2008
Biopharmaceuticals
 HSMN NewsFeed - 17 Dec 2007
Synthetic Blood Announces Oxycyte Development Strategy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Dec 2007
BioMarin Announces FDA Approval for Kuvan
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Dec 2007
Cyberkinetics Receives FDA Response Letter on Andara(TM) OFS(TM) System for Acute Spinal Cord Injury
Devices Neurology
 HSMN NewsFeed - 3 Dec 2007
Researchers Report Results from Study of Brain Electrical Activity Using Cyberkinetics' NeuroPort(TM) System at the American Epilepsy Society Meeting
Devices Neurology
 HSMN NewsFeed - 30 Nov 2007
FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Nov 2007
Technology Innovation: SpineVision(R) is Teaming with Singapore's Bio*One Capital and Beyonics Technology Ltd. to Make Spine Surgery Safer
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 20 Nov 2007
Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials
Regenerative Medicine Neurology Licensing
 HSMN NewsFeed - 20 Nov 2007
Synthetic Blood Announces Major Restructuring
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2007
Cyberkinetics and NeuroMetrix Forge Strategic Alliance and Agree to Pursue Joint Venture Aimed at Developing Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology
 HSMN NewsFeed - 14 Nov 2007
NeuroMetrix Announces Strategic Alliance with Cyberkinetics
Devices Neurology
 HSMN NewsFeed - 9 Nov 2007
Zynex Expands and Moves to Larger Facility
Devices
 HSMN NewsFeed - 31 Oct 2007
Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
Biopharmaceuticals
 HSMN NewsFeed - 30 Oct 2007
Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
Devices Oncology
 HSMN NewsFeed - 25 Oct 2007
Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Oct 2007
Varian Medical Systems to Introduce RapidArc(TM) Radiotherapy Technology for Volumetric Arc Therapy at ASTRO 2007
Devices Oncology
 HSMN NewsFeed - 23 Oct 2007
COPAXONE(R) Significantly Decreases Disease Activity in Patients Who Switched from Interferon Beta (IFNb) Due to Development of Neutralizing Antibodies (NAbs)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Oct 2007
Tengion Closes $33 Million in Series C Funding
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 12 Oct 2007
Long-Term Study Shows COPAXONE(R) Significantly Slows Progression of Disability and Reduces Relapse Rates in Patients with Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Sep 2007
Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Sep 2007
SpineVision(R) Appoints Luis Aparicio as Company's First PediGuard Sales Rep for State of Texas
Devices Orthopaedic Personnel
 HSMN NewsFeed - 19 Sep 2007
Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc.
Regenerative Medicine Neurology Litigation
 HSMN NewsFeed - 18 Sep 2007
Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery
Devices Oncology
 HSMN NewsFeed - 17 Sep 2007
Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
Regenerative Medicine Urology
 HSMN NewsFeed - 17 Sep 2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
Biopharmaceuticals
 HSMN NewsFeed - 16 Sep 2007
Integra NeuroSciences Launches DuraGen XS Dural Regeneration Matrix
Devices Neurosurgery FDA
 HSMN NewsFeed - 14 Sep 2007
Study Shows Medtronic Neurostimulation Therapy Improves Chronic Neuropathic Leg and Back Pain
Devices
 HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
Biopharmaceuticals Oncology Litigation Licensing
 HSMN NewsFeed - 5 Sep 2007
Finland's Nexstim Completes EUR 8 Million Financing Round
Devices Neurology Venture Capital
 HSMN NewsFeed - 29 Aug 2007
Wyeth and Progenics Submit Marketing Application in Australia for Subcutaneous Methylnaltrexone
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Aug 2007
Medtronic Receives Approval for First Artificial Disc for the Neck in the U.S.
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 27 Aug 2007
Geron Scientists and Collaborators Demonstrate Human Embryonic Stem Cell-Derived Cardiomyocytes Improve Heart Function When Transplanted After Myocardial Infarction
Regenerative Medicine Cardiology
 HSMN NewsFeed - 21 Aug 2007
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2007
FDA Grants Tikvah Therapeutics, Inc. Orphan Drug Status for Sodium Phenylbutyrate for the Treatment of Spinal Muscular Atrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Aug 2007
Boston Scientific, Advanced Bionics Principals Announce Strategic Accord
Devices Pain Management
 HSMN NewsFeed - 2 Aug 2007
OncoLogics, Inc., Signs Deal to Bring Proton Beam Radiation Therapy to Louisana
Devices Oncology
 HSMN NewsFeed - 2 Aug 2007
Stem Cell Therapy International Acquires Exclusive Worldwide Rights to New, Anti-Rejection Stem Cell Technology
Regenerative Medicine
 HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Jul 2007
Acorda Therapeutics Announces Resignation of Mary Fisher
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2007
MinSurg Announces Director of Clinical Services
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 17 Jul 2007
Medtronic Receives FDA Panel's Recommendation for Approval of the Bryan(R) Cervical Disc
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 17 Jul 2007
Medtronic Receives Approval for First Artificial Disc for the Neck in the United States
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 16 Jul 2007
Hanger Orthopedic Group, Inc. Announces a Commercialization Agreement Between Its Subsidiary, Innovative Neurotronics, and Teijin Limited for the WalkAide System in the Japanese Market
Devices Licensing
 HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jul 2007
Providence Holy Cross Cancer Center Offers Advanced Image-Guided Radiotherapy Treatments Using New Technology from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 11 Jul 2007
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jul 2007
SurModics and Paragon Intellectual Properties to Collaborate on FINALE(TM) Coated Prohealing Stent to Combat Late Stent Thrombosis
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 2 Jul 2007
Boston Scientific Announces Launch of New Precision Plus(TM) Spinal Cord Stimulation System
Devices Neurology
 HSMN NewsFeed - 27 Jun 2007
Alseres Pharmaceuticals Announces FDA Clearance to Increase Dose Level in Cethrin(R) Phase I/IIa Clinical Trial for Acute Spinal Cord Injury at U.S. Sites
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Jun 2007
Nobel Prize Winning Scientist Joins InVivo Therapeutics Team
Devices Personnel
 HSMN NewsFeed - 18 Jun 2007
Medtronic Receives FDA Approval for New Tripolar, 16-Electrode Neurostimulation Lead to Treat Chronic Pain
Devices FDA
 HSMN NewsFeed - 18 Jun 2007
StemCells, Inc. Announces Important Milestone in Batten Disease Clinical Trial
Regenerative Medicine Neurology
 HSMN NewsFeed - 11 Jun 2007
FDA Accepts and Grants Priority Review of ERBITUX(R) (Cetuximab) sBLA for Overall Survival in Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Jun 2007
Boston Life Sciences, Inc. Changes Name to Alseres Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 7 Jun 2007
SpineVision(R) Reports U.S. Market Penetration Milestone: 250th Spine Surgeon Has Been Trained to Use the Company's FDA-cleared PediGuard(TM) Device
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 7 Jun 2007
Teva and Active Biotech to Initiate Pivotal Phase III Trial Program of Oral Laquinimod for Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Jun 2007
Multiple Hospitals Acquire Second CyberKnife(R) System to Meet Growing Demand for Radiosurgery
Devices Oncology
 HSMN NewsFeed - 6 Jun 2007
Acorda Therapeutics Begins Second Phase 3 Clinical Trial of Fampridine-SR in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2007
Edward Cancer Center Treats Lung Cancer With Novel Adaptive Image-Guided Radiotherapy Using Trilogy(R) Technology from Varian Medical Systems
Devices Oncology
Return to NewsFeed  

 Additional items found! 271

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 271 additional stories matching:
spinal cord
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.